Search clinical trials for: Trizivir (Abacavir Lamivudine Zidovudine)

Total 878 results

Hoffmann-La Roche

Completed

A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B

Hepatitis B, Chronic

China, Hong Kong
ANRS, Emerging Infectious Diseases

Completed

4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients (ANRS162-4D)

HIV-1 Infection

France
Asan Medical Center

Unknown

Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis B

Hepatitis B, Chronic

Korea, Republic of
ViiV Healthcare
GlaxoSmithKline

Completed

Pharmacokinetics, Safety and Tolerability Study of Abacavir/ Dolutegravir/ Lamivudine Fixed-dose Combination Tablets in Healthy Japanese Subjects

Infection, Human Immunodeficiency Virus

United States
The University of Hong Kong

Completed

Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral Load

Hepatitis B, Chronic

China
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Terminated

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy (P1094)

HIV Disease

United States, Puerto Rico, Argentina, Brazil, Thailand
Universidade Federal de Pernambuco

Completed

Bioequivalence Study Between Lamivudine Formulations in the Form of Coated Tablet of 150 mg in Healthy Volunteers

HIV INFECTIONS
Ruijin Hospital

Unknown

An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients

Chronic Hepatitis B
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

HIV Infections | Acquired Immunodeficiency Syndrome
Bristol-Myers Squibb

Withdrawn

Entecavir Plus Adefovir in Lamivudine-Resistant Patients

Hepatitis B, Chronic
Beijing Friendship Hospital
Peking University First Hospital; Peking University People's Hospital; Beijing... and other collaborators

Unknown

Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis

Liver Cirrhosis | Hepatitis B

China
South East Asia Research Collaboration with Hawaii
Thai Red Cross AIDS Research Centre; University of Hawaii; Queen Savang Vadhana...

Completed

A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVP

HIV Infections

Thailand
Fundacion SEIMC-GESIDA
Bristol-Myers Squibb

Completed

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy (SALT)

HIV Infection

Spain
Novartis
Novartis Pharmaceuticals

Completed

Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

Chronic Hepatitis B

China
Novartis
Novartis Pharmaceuticals

Completed

An Extension Study of Telbivudine, Lamivudine or Telbivudine Plus Lamivudine in Patients With Chronic Hepatitis B

Hepatitis B

Canada, France, United States, China
National Center for Global Health and Medicine,...
Ministry of Health, Labour and Welfare, Japan

Completed

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir (SPARE)

HIV Infections

Japan
International Medical Center of Japan
Ministry of Health, Labour and Welfare, Japan

Completed

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

HIV Infections

Japan
Hospital de Granollers

Completed

Study to Evaluate Changes in CD4 on Replacing TDF With ABC or DDI+TDF With ABC+3TC

HIV Infections

Spain
Novartis
Novartis Pharmaceuticals

Completed

A Randomized, Double Blind Trial of LdT (Telbivudine) Versus Lamivudine in Adults With Compensated Chronic Hepatitis B

Chronic Hepatitis B

United States, United Kingdom, Spain, Korea, Republic of, Turkey, Thailand
Catholic University of the Sacred Heart

Completed

Atazanavir and Lamivudine for Treatment Simplification (AtLaS)

HIV Infections

Italy
University Hospital, Basel, Switzerland

Terminated

Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine (SASL28)

Hepatitis, Chronic

Switzerland
National Institute of Allergy and Infectious Diseases...

Withdrawn

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

HIV Infections

United States
Pusan National University Hospital
Yonsei University

Completed

Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNA

Hepatitis B, Chronic

Korea, Republic of
Catholic University of the Sacred Heart

Completed

Raltegravir Switch for Toxicity or Adverse Events (RaSTA)

HIV Infections | HIV/AIDS | Antiretroviral Therapy

Italy
Kaohsiung Medical University Chung-Ho Memorial...

Unknown

Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents

Chronic Hepatitis B

Taiwan
Beijing Ditan Hospital

Unknown

The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children

the Safety of Anti-viral Drugs Used in Late Pregnancy
Bristol-Myers Squibb

Completed

A Study in Korea of Entecavir Versus Lamivudine in Adults With Chronic Hepatitis B Infection

Chronic Hepatitis B

Korea, Republic of
Juan A. Arnaiz

Completed

Intermittent ART in Primary HIV Infection (PHI-IL2)

HIV

Spain
HepNet Study House, German Liverfoundation
Hannover Medical School

Completed

Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With Entecavir

Liver Transplantation | Hepatitis B | Liver Disease

Germany
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir and Insulin Aspart in 2 Separate Injections Twice Daily to Extemporaneous Mixing Injection Regimen Twice Daily - The Paediatric Mixing Trial (MIXING)

Diabetes | Diabetes Mellitus, Type 1

France
Kaohsiung Veterans General Hospital.

Unknown

Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation (HBSAE)

Chronic HBV With Severe Exacerbation

Taiwan
The Wistar Institute

Completed

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

HIV Infections

South Africa
Peking Union Medical College
Ministry of Science and Technology of the People´s Republic of China

Unknown

Study on the Impact of Triptolide Woldifiion on HIV-1 Reservoir In Acute HIV-1 Infection

AIDS/HIV PROBLEM

China
Southeast University, China
Cttq

Completed

Oxymatrine Plus Lamivudine Combination Therapy Versus Lamivudine Monotherapy for Chronic Hepatitis B Infected Subjects

Chronic Hepatitis B

China
Juan A. Arnaiz

Completed

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression (OLE)

HIV Infection

Spain
University of California, San Diego
National Institute of Mental Health (NIMH); National Institutes of Health (NIH)

Completed

Clinical Trial of CNS-targeted HAART (CIT2)

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)

HIV Infections

United States
French National Agency for Research on AIDS and...
University of Bergen; The Research Council of Norway; European and Developing... and other collaborators

Completed

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

HIV Infections

Burkina Faso, South Africa, Uganda, Zambia
PENTA Foundation

Completed

PENTA15: Pharmacokinetic Study of Once Versus Twice Daily Abacavir in HIV-1 Infected Children Aged 3 to <36 Months (PENTA15)

HIV Infection

France, Germany, Italy, Spain, United Kingdom
Korea University
GlaxoSmithKline

Completed

Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) (ALTER)

Chronic Hepatitis B

Korea, Republic of
Asan Medical Center

Completed

Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir (CAESAR)

Hepatitis B, Chronic

Korea, Republic of
Yonsei University
Bristol-Myers Squibb; Chonbuk National University Hospital; Seoul St. Mary's... and other collaborators

Unknown

Antiviral Efficacy of Switching to ETV Plus TDF

Chronic Hepatitis B
Fudan University

Unknown

Incidence of Hepatitis B Virus (HBV) Reactivation in HBsAg Negative/HBcAb Positive Lymphoma Patients Treated With RCHOP (IHBVRL)

Lymphoma

China
Gilead Sciences

Approved for marketing

An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options

Chronic Hepatitis B
Bristol-Myers Squibb

Completed

Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus (DEFINE)

Hepatitis B, Chronic

Australia, Korea, Republic of, Taiwan, Thailand, Hong Kong, United States, Poland, Greece, Canada, Singapore, Philippines, Brazil, India, Indonesia, Italy, Malaysia, Russian Federation, Turkey
PENTA Foundation

Completed

Pharmacokinetic (PK) Study of Twice Daily vs Once Daily Lamivudine (3TC) and Abacavir (ABC) as Part of Combination Antiretroviral Therapy (ART) in HIV Infected Children (PENTA 13)

HIV Infection

United Kingdom
Nanfang Hospital of Southern Medical University
GlaxoSmithKline; Major Science and Technology Special Project of China Eleventh...

Completed

Efficacy Optimizing Research of Lamivudine Therapy (EXPLORE)

Compensated Chronic Hepatitis B

China
Fundacion SEIMC-GESIDA
Abbott

Completed

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC (KALIPO)

HIV Infections | HIV Infection

Spain
Ain Shams University

Completed

Resistance to Lamivudine in HBV Egyptian Patients

Chronic Hepatitis B Virus Treatment

Egypt
Hospital Authority, Hong Kong

Completed

A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

Neoplasms | Hepatitis B

China

3

Subscribe